Skip to main content
# Title Department Research Year
41 Selective and reliable fluorometric quantitation of anti-cancer drug in real plasma samples using nitrogen-doped carbon dots after MMIPs solid phase microextraction: Monitoring methotrexate plasma level Department of Pharmaceutical Analytical Chemistry 2024
42 Regiodivergent biosynthesis of bridged bicyclononanes Department of Pharmacognosy 2024
43 Development of Oral Formulation of Lepidium Seeds Significantly Decreases the High Blood Glucose Levels in Diabetic Rats; In Vitro Formulation and In Vivo Antidiabetic Performance. Department of Industrial Pharmacy 2024
44 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
45 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit incidence, types, and acceptability Department of Clinical Pharmacy 2024
46 MCT4 knockdown by tumor microenvironment-responsive nanoparticles remodels the cytokine profile and eradicates aggressive breast cancer cells Department of Industrial Pharmacy 2024
47 Antiviral activity of sulphated specialized metabolites from sea urchin Clypeaster humilis: in vitro and in silico studies Department of Pharmaceutical Organic Chemistry 2024
48 Synthesis, Characterization, Antibacterial Evaluation, and Insecticidal Activity of Some Heterocyclic Compounds Containing Styrylpyridine Moiety Department of Pharmaceutical Organic Chemistry 2023
49 Design, synthesis and antiproliferative evaluation of lipidated 1, 3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors‏ Department of Pharmaceutical Organic Chemistry 2023
50 Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl) Quinolin-2(1H)-Ones as Multi-Target Inhibitors Department of Pharmaceutical Organic Chemistry 2023